Details

Last Funding Type

Series C

Last Funding Money Raised

¥800M

Industries

Biopharma,Biotechnology,Pharmaceutical

Founded date

Jan 1, 2013

Number Of Employee

11 - 50

Operating Status

Active

Molcure is antibody and Peptide drug-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of patients by developing and providing more effective therapeutics and supportive care products. Molcure represents high quality antibody and target discovery. With cutting edge technology in-house, Molcure is the partner of choice for therapeutic antibody discovery. At Molcure they combine a deep knowledge of NGS, bioinformatics and antibody biology with automated discovery system. The antibody discovery platform Abtracer delivers superior functional antibodies. Their technology is validated through a number of partnerships. They are seeking new partnership opportunities.